Vascular Graft Division
Terumo Aortic
Treatment of aortic disease with innovative technologies
Terumo Aortic, a new brand formed from two leading companies in the treatment of aortic disease: Bolton Medical of the United States and Vascutek of the United Kingdom, as part of the Japan-based global healthcare company Terumo.
With a focus on the treatment of thoracic and abdominal aortic disease using surgical and stent grafts, Terumo Aortic provides a comprehensive portfolio tailored to meet the needs of surgeons, contributing to the treatment of over 2 million patients in excess of 90 countries globally.
How do we treat aortic disease？
Aortic aneurysm and dissection can lead to a life-threatening rupture and malperfusion of the aorta; suitable treatment with a surgical graft or implantation of a stent graft can help save a patient's life. There is also a hybrid treatment option which is a combination of surgical and endovascular procedures.
Main Products
Hiển thị kết quả xổ số miền bắcNote: The regulatory approval status and availability of these products differ by country or region.
Surgical Grafts
-
Hiển thị kết quả xổ số miền bắcThoracic vascular graft
-
Abdominal vascular graft
Hybrid Graft
Stent Grafts
-
Hiển thị kết quả xổ số miền bắcThoracic stent graft
-
Hiển thị kết quả xổ số miền bắcAbdominal stent graft
-
Hiển thị kết quả xổ số miền bắcAbdominal stent graft
Related Links
O
P